Yesterday, the VP & Principal Accounting Offi of Intuitive Surgical (ISRG), Jamie Samath, sold shares of ISRG for $731.9K.
Following Jamie Samath’s last ISRG Sell transaction on July 25, 2017, the stock climbed by 234.9%.
See today’s analyst top recommended stocks >>
Based on Intuitive Surgical’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $1.05 billion and quarterly net profit of $293 million. In comparison, last year the company earned revenue of $892 million and had a GAAP net loss of $38.8 million. ISRG’s market cap is $62.96B and the company has a P/E ratio of 57.94. Currently, Intuitive Surgical has an average volume of 572.1K.
One of the top 25 analysts, according to TipRanks.com, recently recommended Buy ISRG with a $625 price target. Based on 10 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $573.63, reflecting a 4.3% upside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
